What’s behind the journey of building a platform-driven biotech company? Our CEO, Dragan Grabulovski, sat down with @pharmaboardroom to share his experience as a biotech entrepreneur. Read the full article here: pharmaboardroom.com/intervie… #ADCs #interview #Biotech #ArarisBiotech

Proud to announce our founding team has won the 2025 Strüngmann Award for breakthrough ADC technology! Thank you for recognizing our mission!💙 globenewswire.com/news-relea…

Our CSO, Philipp Spycher, will speak at the Antibody Industrial Symposium (AIS) on June 25! Tune in for insights on the future of ADCs and biotech innovation. #AIS2025 #ADC #Biotech

Araris Biotech is heading to #BIO2025 in Boston (June 16-19)! Meet our team to learn about our ADC pipeline and multi-payload AraLinQ™ technology. DM to connect! #Biotech #ADC #Araris #CancerResearch #ADCs

Our CBO, Filippo Mulinacci, will be attending BIO International in Boston from 16-19 June. Reach out to find out more about our innovative ADC pipeline and multi-payload AraLinQ™ technology. #Araris #BIO2025 #ADCs #conference #networking

Our CBO, Filippo Mulinacci, sat down with Emma Ulker from @NatureBiotech, to speak about his career so far. Read the full article here: nature.com/articles/d41586-0… #Araris #Interview #Career #Biotech #ADC

We are thrilled to announce a research agreement with Johnson & Johnson to develop next-generation antibody drug conjugates (ADCs) using our AraLinQ™ technology. Read the full announcement here: ararisbiotech.com/docs/arari… #Araris #CancerResearch #ADCs #Partnership

Next week, our co-founder and CTO, Isabella Attinger-Toller, will be presenting our latest next-generation ADC technology developments at the @AACR Annual Meeting 2025 in Chicago! #AACR25 #ADCTherapeutics #CancerResearch #ArarisBiotech #Conference

We are pleased to see our innovative antibody conjugation technology featured on the cover of the April issue of ChemBioChem! Read the publication here: chemistry-europe.onlinelibra… #ADC #ChemBioChem #Araris

We are excited to announce the publication of our latest preclinical data in @AACR’s Molecular Cancer Therapeutics, showcasing the power of our next-generation ADC technology: ararisbiotech.com/docs/25040… #ADCTherapeutics #OncologyInnovation #Biotech #ArarisBiotech